Digital Conferences - Call Replay: Transcript of Call: Participants Lane Desborough, KOL Davida Kruger, KOL Jeb Besser, MODD CEO Deniel Mero, PropThink Editor PropThink Good afternoon everyone, welcome … Continue Reading
Read nowTranscripts - Participants Matt Kapusta, Chief Executive Officer Ricardo Dolmetsch, President of R&D Sara Tabrizi, KOL Maria Cantor, Chief Corporate Affairs Officer Maria Cantor, Chief Corporate Affairs Officer Good morning, … Continue Reading
Read nowTranscripts - Webcast: https://player.vimeo.com/video/833811575?badge=0&autopause=0&player_id=0&app_id=58479%22 Participants William Doyle, Executive Chairman Ticiana Leal, Emory University Corey J Langer, University of Pennsylvania Pritesh Shah, Chief Growth Officer Ashley Cordova, Chief … Continue Reading
Read nowResearch - Genocea is using neoantigens to develop a cancer vaccine that can add precision to TIL therapy and improve its efficacy. Iovance has validated TIL therapy. … Continue Reading
PremiumInsights - La Jolla Pharma (LJPC) is a beat up contrarian play that has dropped roughly 70% since September. Why? Because: (1) Commercial launch of Giapreza has … Continue Reading
PremiumEducation - How the FDA's approval processes differ, a investor's guide. Including Breakthrough Therapy, Accelerated Approval, Priority Review, and Fast Track.
Read nowInterviews - Operator: Thank you for holding. Welcome to the Selecta Biosciences fourth quarter and year end 2017 conference call. Currently all participants are in a listen … Continue Reading
Read now
